Thus, the main objective of the present study was to quantitatively evaluate NGAL as an early predictor of acute kidney injury and to assess the levels of two non-collagenous matrix glycoproteins—fibronectin and laminin—in the urine of obese patients with T2DM following anti-diabetic therapy with metformin. Here, LCN2 is linked to type 2 diabetes mellitus.